FDA Clearance Tracker · P160017-S089
MiniMed 670G System, MiniMed 770G System
Last checked: Nov 20, 2026Latest source record: Apr 19, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Apr 19, 2021
Approved
Time to decision
123 days
Received Dec 17, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P160017-S089
- Device name
- MiniMed 670G System, MiniMed 770G System
- Applicant
- Medtronic Minimed, Inc.
- Applicant location
- Northridge, CA
- Received
- Dec 17, 2020
- Decided
- Apr 19, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P160017
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval to introduce the MiniMed 770G System to the post-approval study and to provide protocol updates to meet enrollment requirements.
Source documents
Other decisions for Medtronic Minimed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MiniMed Flex pump510(k)
K253743 · Decided Mar 12, 2026 · 108 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.